At the time of writing, Werewolf Therapeutics Inc [HOWL] stock is trading at $1.79, down -2.72%. An important factor to consider is whether the stock is rising or falling in short-term value. The HOWL shares have gain 23.45% over the last week, with a monthly amount glided 35.61%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Werewolf Therapeutics Inc [NASDAQ: HOWL] stock has seen the most recent analyst activity on April 03, 2024, when JMP Securities initiated its Mkt Outperform rating and assigned the stock a price target of $12. Previously, Wedbush started tracking the stock with Outperform rating on August 24, 2023, and set its price target to $9. BofA Securities started tracking the stock assigning a Buy rating and suggested a price target of $26 on September 10, 2021. SVB Leerink initiated its recommendation with a Outperform and recommended $29 as its price target on May 25, 2021. Jefferies started tracking with a Buy rating for this stock on May 25, 2021, and assigned it a price target of $22. In a note dated May 25, 2021, H.C. Wainwright initiated a Buy rating and provided a target price of $32 on this stock.
For the past year, the stock price of Werewolf Therapeutics Inc fluctuated between $0.60 and $4.18. Currently, Wall Street analysts expect the stock to reach $12 within the next 12 months. Werewolf Therapeutics Inc [NASDAQ: HOWL] shares were valued at $1.79 at the most recent close of the market. An investor can expect a potential return of 570.39% based on the average HOWL price forecast.
Analyzing the HOWL fundamentals
According to Werewolf Therapeutics Inc [NASDAQ:HOWL], the company’s sales were 0.00M for trailing twelve months, which represents an -100.00% plunge. To continue investigating profitability, this company’s Return on Assets is posted at -0.79, Equity is -1.12 and Total Capital is -0.94. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.24.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.5967 points at the first support level, and at 1.4033 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.1067, and for the 2nd resistance point, it is at 2.4233.
Ratios To Look Out For
It is important to note that Werewolf Therapeutics Inc [NASDAQ:HOWL] has a current ratio of 5.30. On the other hand, the Quick Ratio is 5.30, and the Cash Ratio is 5.17.
Transactions by insiders
Recent insider trading involved RA CAPITAL MANAGEMENT, L.P., Director, that happened on May 12 ’25 when 0.32 million shares were purchased. Director, RA CAPITAL MANAGEMENT, L.P. completed a deal on May 14 ’25 to buy 0.16 million shares. Meanwhile, Director RA CAPITAL MANAGEMENT, L.P. bought 52974.0 shares on May 13 ’25.